Pistolese M, Boccadamo R, Altamura G
G Ital Cardiol. 1980;10(1):37-47.
The Authors refer on the methods and the results of permanent electrical treatment with atrial demand pacemakers and radio-frequency systems in 6 cases of brady-tachy syndrome and in 2 cases of recurrent supraventricular tachycardia refractory to drug therapy. In the 6 patients with brady-tachy syndrome atrial demand pacemakers with incorporated radiofrequency receiver were employed; in the 2 patients with supraventricular tachycardia a subcutaneous receiver for radiofrequency stimulation was implanted. The catheters employed were: in 3 patients screw-in leads placed in the right atrial appendage and in 5 unipolar sinus coronary leads. The patient-activated transmitter is been realized in two models: the first one can emit short bursts of eight impulses at the rates of 150-220-260 b/m, each one is selectable by the patient; the number and the period of the beats of the second transmitter can be programmed only by one of us; the stimulator is then given to the patient with a personalized fixed program accordingly to the electrophysiological and clinical observations. During a mean follow up of 7.7 months the safety of the leads both for the stability and the electrical behaviour was noticed in all patients but one with a coronary sinus lead in which a stimulation failure was noticed after the eighth month of stimulation because of high threshold requiring the implantation of a ventricular pacemaker. In the brady-tachy syndrome cases the treatment had a considerable antiarrhythmic efficacy, each patient showing a reduction of hyperkinetic episodes and the ability to interrupt them. In the two cases of refractory supraventricular tachycardia a complete control of the episodes by overdrive stimulation was obtained.
作者介绍了采用心房按需起搏器和射频系统对6例缓慢性心律失常综合征患者以及2例药物治疗无效的复发性室上性心动过速患者进行永久性电治疗的方法和结果。在6例缓慢性心律失常综合征患者中,使用了内置射频接收器的心房按需起搏器;在2例室上性心动过速患者中,植入了皮下射频刺激接收器。所使用的导管包括:3例患者采用旋入式电极导线置于右心耳,5例采用单极窦房结冠状窦电极导线。患者激活的发射器有两种型号:第一种可以以150-220-260次/分钟的速率发射8个脉冲的短脉冲串,每个速率可由患者选择;第二种发射器的搏动次数和周期只能由我们中的一人进行编程;然后根据电生理和临床观察结果,为患者提供个性化的固定程序刺激器。在平均7.7个月的随访期间,除1例冠状窦电极导线患者外,所有患者的电极导线在稳定性和电性能方面均表现出安全性,该例患者在刺激8个月后出现刺激失败,原因是阈值过高,需要植入心室起搏器。在缓慢性心律失常综合征病例中,治疗具有显著的抗心律失常疗效,每位患者的心动过速发作次数均减少,且能够中断发作。在2例难治性室上性心动过速病例中,通过超速刺激实现了对发作的完全控制。